Pharmafile Logo
Pharmafocus logo
Advanced Search

European medicines legislation and pharmacovigilance

October 20, 2010
Research and Development NDA, pharmacovigilance, regulatory affairs

During the past decade, changes in European medicines legislation and guidelines have increased the scope and regulatory scrutiny of pharmacovigilance …

Feature

UK science in line for £500m boost from EU

October 20, 2010
Research and Development UK Biobank, UKCMRI, biotech funding, life sciences, science parks

The European Investment Bank has unveiled a £500 million package of loans to boost the UK’s science and education base …

News

FDA approves Boehringer’s Pradaxa

October 20, 2010
Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …

News

FDA warns of bisphosphonates fracture risk

October 20, 2010
Sales and Marketing Boniva, Fosamax, Reclast, actonel, bisphosphonates, osteoporosis

The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …

News
Pharma association the ABPI

NICE needs narrower focus, says ABPI

October 20, 2010
Sales and Marketing ABPI, NICE, value

NICE’s remit should be changed to give it a greater focus on the value of innovation, according to UK pharma …

News

King’s Fund appoints Kaye Lobley to leadership post

October 20, 2010
UK, appointment, king's fund

Kate Lobley will take up the post of director of leadership at health think tank The King’s Fund on 1 …

Appointment

Apixaban trial for ACS abandoned

October 20, 2010
Sales and Marketing ACS, BMS, Pfizer, apixaban

  Pfizer and Bristol-Myers Squibb have halted a trial of their heart drug apixaban after signs of increased risk of …

News
DH Information Revolution

Digital Pharma: NHS to lead an ‘information revolution’

October 19, 2010
Medical Communications Digital Pharma blog, electronic patient records, patient information

Patients could soon be able to contact their doctor online as part of government plans for an ‘information revolution’ in …

News

Hill & Knowlton appoints Damaris Anderson-Supple

October 19, 2010
Medical Communications Hill & Knowlton, appointment, medical communications

PR agency Hill & Knowlton has appointed Damaris Anderson-Supple to the newly created position of chief operating officer for its …

Appointment

Reaxa spins out specialist antibody-drug conjugate unit

October 19, 2010
Manufacturing and Production Mylotarg, Reaxa, antibody-drug conjugates

UK company Reaxa is spinning out a new company called ADC Biotechnology to develop and commercialise an improved purification technology …

News

NHS Confederation warns on health cuts

October 19, 2010
NHS, NHS Confederation, government

In the week of the Comprehensive Spending Review, the NHS Confederation has painted a dire picture of the effect of …

News

Pfizer opens £26m UK packaging facility

October 19, 2010
Business Services, Manufacturing and Production Pfizer, packaging, recruitment

Pfizer officially opened a new biotechnology packaging facility in Hampshire, UK, on October 15, with a ceremony attended by UK …

News
Dr Ben Goldacre

Dr Ben Goldacre: “This is a very broken system”

October 19, 2010
Medical Communications, Research and Development, Sales and Marketing Bad Science, Ben Goldacre, industry reputation, trial data

The pharma industry has its fair share of critics, but unfortunately for everybody, many are easy to dismiss – shrill, …

Feature

GSK collaborates on rare genetic diseases

October 19, 2010
Research and Development Fondazione San Raffaele, Fondazione Telethon, GlaxoSmithKline, Stem cells, gene therapy

GlaxoSmithKline has partnered with one of the biggest biomedical charities in Italy and the country’s largest private research institute to …

News

Bayer’s Xarelto hailed at Prix Galien

October 19, 2010
Research and Development Firazyr, Xarelto, prix galien

Bayer’s Factor Xa anticoagulant Xarelto scooped the Best Pharmaceutical Agent award at the prestigious Prix Galien ceremony. Xarelto is part …

News

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010
Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …

Feature

Sanofi signs translational research deal with Harvard

October 18, 2010
Research and Development Harvard, Sanofi-Aventis, academia, translational

Sanofi-Aventis is to collaborate on translational biomedical research with Harvard University in therapy areas such as cancer, diabetes and inflammation. …

News

Trial shows long-term benefits of Novartis’ Aclasta

October 18, 2010
Research and Development, Sales and Marketing Novartis, aclasta, osteoporosis

Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …

News

27 health quangos cut or ‘reconstituted’

October 18, 2010
NHS, government

The coalition government’s review of its health advisory bodies won’t end with the abolition of 10 healthcare quangos, among them …

News
2fe094c

IDEA Pharma appoints Tony Akiwumi

October 18, 2010
Sales and Marketing Go-To-Market Strategy, IDEA Pharma, IDEAtion, Phase II, appointment, sales and marketing

Tony Akiwumi has joined Idea Pharma as director of client value, moving to the strategic marketing consultancy from Quintiles.He will lead …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026